Albany Molecular Research Inc
AMRI
AMRI was delisted on the 31st of August, 2017.
113 hedge funds and large institutions have $515M invested in Albany Molecular Research Inc in 2014 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 37 increasing their positions, 36 reducing their positions, and 28 closing their positions.
144% more call options, than puts
Call options by funds: $6.15M | Put options by funds: $2.52M
95% more capital invested
Capital invested by funds: $264M → $515M (+$251M)
3% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 36
4% less funds holding
Funds holding: 118 → 113 (-5)
18% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 28
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$13.3M |
| 2 |
HM
HealthCor Management
New York
|
+$12.4M |
| 3 |
DCM
Decade Capital Management
New York
|
+$8.95M |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
+$7.21M |
| 5 |
HVC
Healthcare Value Capital
Woodcliff Lake,
New Jersey
|
+$6.17M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$15.9M |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$8.91M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$2.47M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$2.42M |
| 5 |
SFM
Systematic Financial Management
Teaneck,
New Jersey
|
-$1.73M |
AMRI Hedge Fund Activity: Q1 2014 in Review
113 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Albany Molecular Research Inc (AMRI) for Q1 2014, worth a combined $515M — up 95% from $264M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of AMRI and 23 opened new positions — a net loss of 5 holders — while 36 trimmed existing stakes and 37 added.
The largest buyer was Millennium Management, adding an estimated $13.3M. The largest seller was Wellington Management Group, cutting an estimated $15.9M.
- 113 institutional investors held Albany Molecular Research Inc (AMRI) as of Q1 2014, down from 118 in Q4 2013.
- Funds reported $515M of Albany Molecular Research Inc stock for Q1 2014, up 95% quarter-over-quarter.
- 23 funds opened new Albany Molecular Research Inc positions in Q1 2014 and 28 closed out, a net change of -5 holders.
- The largest Albany Molecular Research Inc buyer in Q1 2014 was Millennium Management, an estimated $13.3M added.
- The largest Albany Molecular Research Inc seller in Q1 2014 was Wellington Management Group, an estimated $15.9M sold.
Based on aggregated 13F filings for Q1 2014.